Frontal Fibrosing Alopecia: A Disease Fascinating for the Researcher, Disappointing for the Clinician and Distressing for the Patient

The commentary discusses Frontal Fibrosing Alopecia (FFA), a primary scarring alopecia that has become increasingly common and is of great interest to researchers due to its unclear etiology. The authors highlight the need for research into the genetic and environmental factors contributing to FFA, noting a study that suggests a link between the use of facial sunscreens and the disease. Clinically, FFA is challenging as it causes distressing hair loss with no effective medical therapies to reverse it, and hair transplants are not guaranteed to be successful. The authors suggest that drugs effective in treating other autoimmune conditions, such as Janus Kinase (JAK) inhibitors and Apremilast, could be potential treatments for FFA. The commentary concludes that understanding the pathogenesis of FFA is crucial for developing effective treatments and that more research is needed to identify environmental triggers and improve therapeutic strategies.